Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Lamivudine + unspecified PD-1 antibody |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Lamivudine | Epivir | 3TC | Epivir (lamivudine) is a nucleoside analog that inhibits reverse transcriptase upon incorporation leading to viral DNA chain termination, and is used in anti-retroviral therapy (PMID: 10066527). | |
unspecified PD-1 antibody | Experimental PD-1 antibody | Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 119 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06494579 | Phase Ib/II | Lamivudine Lamivudine + unspecified PD-L1 antibody Lamivudine + unspecified PD-1 antibody | Lamivudine for Solid Tumors | Not yet recruiting | USA | 0 |